Although differential grafting potential of highly cycling fetal liver-derived cells compared to adult BM cells might have influenced these experiments, pediatric but not adult KMT2A–MLLT3+ leukemia often express lymphoid markers, strongly suggesting that activation at a particular developmental stage significantly influences disease biology. This evidence concerns the gene MLLT3 and leukemia.